NASDAQ:RGLS
USD
7.85
- (0.3%)
REGULUS THERAPEUTICS INC.
Industry: Biotechnology
End of Day: 7 May 2025 GMT-4
USD 7.850
- (0.3%)
End of Day: 7 May 2025 GMT-4
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory ...
Key Ratios
more
Income
more
Total Revenues (USD, MM)
-
Net Income (USD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (USD, MM)
-
Total Liabilities (USD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (USD, MM)
-
Investing (USD, MM)
-
Financing (USD, MM)
-
Make Smart Investment Choices